Trial Profile
Effectiveness Of Biosimilar Epoetin Alfa For The Treatment Of Chemotherapy-Induced Anemia In Patients With Hematological Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2014
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- 23 Apr 2014 New trial record